REVB

Revelation Biosciences

• Benzinga·11h ago

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• TipRanks·1d ago

  Revelation Biosciences announces formation of AKI advisory board

• TipRanks·03/30 19:56

  Revelation Gemini data show ‘broad effect,’ says Roth Capital

• TipRanks·03/30 13:21

  Revelation Biosciences presents additional data from Prime Clinical Study

• Benzinga·03/30 13:02

  Revelation Biosciences Presents Additional Data Analysis From PRIME Study At International Conference On AKI & CRRT 2026

• Reuters·03/30 13:02

  Revelation Biosciences says Gemini normalizes inflammation in PRIME study CKD patients

• Reuters·03/24 13:00

  Revelation Biosciences to host fireside chat at the 38th Annual Roth Conference

• TipRanks·03/19 20:51

  Revelation Biosciences Shareholders Approve Warrant Share Issuance

• Reuters·03/19 20:19

  Revelation Biosciences held a special shareholder meeting

• Reuters·03/19 13:00

  Revelation Biosciences to host fireside chat at Roth Conference

• TipRanks·02/27 13:39

  Revelation Biosciences price target lowered to $16 from $20 at Roth Capital

• Seeking Alpha·02/27 12:02

  Revelation Biosciences reports FY results

• Reuters·02/26 22:00

  Revelation Biosciences Q4 net loss widens

• Benzinga·02/26 21:49

  Revelation Biosciences Q4 EPS $(1.65) Misses $(0.96) Estimate

• Benzinga·01/30 21:20

  Revelation Biosciences Files Prospectus For The Resale Of 4,272,500 Shares Via Warrants For Potential Proceeds Up To ~$14.7M